Soleno Therapeutics
Definition
A biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, particularly hyperphagia associated with Prader-Willi syndrome.
The maker of Vykat XR, the first FDA-approved treatment for hyperphagia in Prader-Willi syndrome patients aged 4 and older.
Examples
Investors cheered as Neurocrine snapped up Soleno Therapeutics for $2.9 billion, turning rare disease research into a not-so-rare windfall.
My hypochondriac friend swears Soleno Therapeutics will cure his 'rare' aversion to exercise someday.
In the world of biotech, Soleno Therapeutics just pulled off the kind of blockbuster deal that makes Wall Street forget about all those clinical trial flops.
Soleno Therapeutics' Vykat XR isn't just a drug; it's the ultimate appetite suppressant for those with Prader-Willi – and maybe for my fridge raids too.